Paper41766366
Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review.
Saavedra DI and 7 others. Pharm Biol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review. Papers, record 41766366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41766366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Turmeric (curcuma longa) rhizome essential oil: analytical profile of authenticated and commercial samples, safety and pharmacology review.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Curcuma | Major topic |
| Oils, Volatile | Major topic |
| Rhizome | Major topic |
| Drug Contamination | Major topic |
| Plant Oils | Major topic |
| Plant Extracts | Major topic |
| Animals | |
| Humans | |
| Gas Chromatography-Mass Spectrometry | |
| India |
Source PubMed
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23229920 | Immune activation and antitumor response of ar-turmerone on P388D1 lymphoblast cell implanted tumors. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/23229920 | PubMed |
| 2 | 37249978 | The role of Curcuma longa essential oil in controlling acute toxoplasmosis by improving the immune system and reducing inflammation and oxidative stress. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37249978 | PubMed |
| 3 | 29316908 | Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. | BMC Complement Altern Med | 2018 | https://conductscience.org/library/papers/29316908 | PubMed |
| 4 | 33066856 | Effect of Turmacin supplementation on joint discomfort and functional outcome among healthy participants - A randomized placebo-controlled trial. | Complement Ther Med | 2020 | https://conductscience.org/library/papers/33066856 | PubMed |
| 5 | 31345163 | Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. | BMC Gastroenterol | 2019 | https://conductscience.org/library/papers/31345163 | PubMed |
| 6 | 35893636 | Analysis of Volatile Constituents in Curcuma Species, viz. C. aeruginosa, C. zedoaria, and C. longa, from Nepal. | Plants (Basel) | 2022 | https://conductscience.org/library/papers/35893636 | PubMed |
| 7 | 21345376 | Development of a quantitative bioassay to assess preventive compounds against inflammation-based carcinogenesis. | Nitric Oxide | 2011 | https://conductscience.org/library/papers/21345376 | PubMed |
| 8 | 33041781 | Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33041781 | PubMed |
| 9 | 22728094 | Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia. | Int Immunopharmacol | 2012 | https://conductscience.org/library/papers/22728094 | PubMed |
| 10 | 25928248 | Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. | Stem Cell Res Ther | 2014 | https://conductscience.org/library/papers/25928248 | PubMed |
| 11 | 29027274 | Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study. | Phytother Res | 2017 | https://conductscience.org/library/papers/29027274 | PubMed |
| 12 | 34063571 | Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities. | Cells | 2021 | https://conductscience.org/library/papers/34063571 | PubMed |
| 13 | 34583214 | ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial. | Mult Scler Relat Disord | 2021 | https://conductscience.org/library/papers/34583214 | PubMed |
| 14 | 35794287 | Aromatic-turmerone ameliorates DSS-induced ulcerative colitis via modulating gut microbiota in mice. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35794287 | PubMed |
| 15 | 28850308 | A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study. | J Med Food | 2017 | https://conductscience.org/library/papers/28850308 | PubMed |
| 16 | 20438793 | Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. | Food Chem Toxicol | 2010 | https://conductscience.org/library/papers/20438793 | PubMed |
| 17 | 32565848 | Biocurcumin as Radiosensitiser for Cervical Cancer Study (BRACES): A Double-Blind Randomised Placebo-Controlled Trial. | Evid Based Complement Alternat Med | 2020 | https://conductscience.org/library/papers/32565848 | PubMed |
| 18 | 30717336 | Variations in the Volatile Compositions of Curcuma Species. | Foods | 2019 | https://conductscience.org/library/papers/30717336 | PubMed |
| 19 | 22766494 | Aromatic-turmerone's anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling. | Neurochem Int | 2012 | https://conductscience.org/library/papers/22766494 | PubMed |
| 20 | 6686573 | Monographs on fragrance raw materials. | Food Chem Toxicol | 1983 | https://conductscience.org/library/papers/6686573 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42860821 | From tradition to translational medicine: advances and controversies in turmeric and curcumin research. | Pharm Biol | 2026 | https://conductscience.org/library/papers/42860821 | PubMed |
| 42797524 | Beyond the Rhizome: Phytochemistry, Biological Activities, and Sustainable Utilization of Curcuma longa L. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797524 | PubMed |
| 42356474 | Bioactive Constituents, Mechanisms, and Complementary Therapeutic Applications of Food-Medicine Continuum Materia Medica for Atherosclerosis Prevention and Treatment. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356474 | PubMed |
| 42121549 | 10-Hydroxy-2-decenoic Acid Suppresses Colorectal Cancer Progression by Inhibiting Wnt/β-Catenin Signaling and Promoting Apoptosis. | Foods | 2026 | https://conductscience.org/library/papers/42121549 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41766366
GET https://conductscience.org/api/papers/v1/41766366/references?page=2